SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001144204-18-038363
Filing Date
2018-07-13
Accepted
2018-07-13 17:16:46
Documents
11
Period of Report
2018-07-13

Document Format Files

Seq Description Document Type Size
1 PREM14A tv498401-pre14a.htm PREM14A 6205261
2 GRAPHIC lg_tapimmune.jpg GRAPHIC 49168
3 GRAPHIC sg_nomura-secintl.jpg GRAPHIC 22438
4 GRAPHIC tv498401_header.jpg GRAPHIC 18492
5 GRAPHIC tv498401_img-clinical.jpg GRAPHIC 104897
6 GRAPHIC tv498401_img-heterogeneous1.jpg GRAPHIC 8947
7 GRAPHIC tv498401_img-heterogeneous2.jpg GRAPHIC 390647
8 GRAPHIC tv498401_img-sctdonor.jpg GRAPHIC 598312
9 GRAPHIC tv498401_pc1.jpg GRAPHIC 600054
10 GRAPHIC tv498401_pc2.jpg GRAPHIC 838123
11 GRAPHIC tv498401_table.jpg GRAPHIC 344122
  Complete submission text file 0001144204-18-038363.txt   10299818
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
TAPIMMUNE INC. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-37939 | Film No.: 18953127
SIC: 2834 Pharmaceutical Preparations